When a patient on one of these medicines comes to us complaining that food tastes different or smells are off, we should consider the drug as a possible reason, not brush it aside
Private-pay users need support after medication changes because NHS access may be limited and waiting times can be long
New obesity drug boosts GLP-1 weight loss without added side effects A new class of weight-loss drug has shown it can significantly boost weight loss when paired with GLP-1 therapy without adding side effects in a mid-stage clinical trial, pointing to a powerful new combination approach to tackling obesity
J., Jensen-Jarolim, E., Fischer, D
Lancet Diabetes Endocrinol (2014) 2(1):3845.10.1016/S2213-8587(13)70070-6 16 NguyenKTBillingtonCJVellaAWangQAhmedLBantleJPet alPreserved insulin secretory capacity and weight loss are the predominant predictors of glycemic control in patients with type 2 diabetes randomized to Roux-en-Y gastric bypass